Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)
PRECISE
Study on the Function of Insulin-producing Beta Cells in the Human Pancreas
1 other identifier
observational
400
1 country
1
Brief Summary
The study investigates the mechanisms underlying the pathogenesis of diabetes by examining structural and functional properties of islets of Langerhans in pancreas specimen from patients undergoing (partial) pancreatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 21, 2012
CompletedFirst Submitted
Initial submission to the registry
September 12, 2019
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2035
November 29, 2023
November 1, 2023
18.4 years
September 12, 2019
November 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Glycated hemoglobin
Proportion of glycated HbA1c (in %) as determined from pre-operative serum samples
1 year
Secondary Outcomes (1)
Islet area
1 year
Study Arms (3)
Type 2 diabetes
Patients with type 2 diabetes undergoing (partial) pancreatectomy
Type 3 diabetes
Patients with type 3 diabetes undergoing (partial) pancreatectomy
Non-diabetic controls
Patients with normal glucose metabolism undergoing (partial) pancreatectomy
Interventions
The participants did not receive any study-specific intervention
Eligibility Criteria
patients with or without diabetes who undergo (partial) pancreatectomy
You may qualify if:
- ability to give informed consent
You may not qualify if:
- denial of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- German Diabetes Centerlead
- Lukas Hospital, Neuss, Germanycollaborator
- Heinrich-Heine University, Duesseldorfcollaborator
- Florence Nightingale Hospital, Düsseldorf, Germanycollaborator
Study Sites (1)
German Diabetes Center
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Related Publications (1)
Böddeker J-S, Burkart V, Strassburger K, Goretzki P, Knoefel W-T, Möbius C, Bug R, Hinsch N, Esposito I, Gerharz CD, Roden M, Müssig K. Diabetes in Patients with Pancreatic Cancer: Relationship of Tumor Grade with Glycemic Control. Diabetes 2019; 68 (Suppl 1) DOI: https://doi.org/10.2337/db19-434-P
RESULT
Biospecimen
Pancreatic tissue, visceral adipose tissue and serum samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Roden, Prof MD
German Diabetes Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2019
First Posted
November 29, 2023
Study Start
August 21, 2012
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2035
Last Updated
November 29, 2023
Record last verified: 2023-11